PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.24%
Revenue growth above 1.5x RUN's 2.54%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-253.92%
Negative gross profit growth while RUN is at 36.73%. Joel Greenblatt would examine cost competitiveness or demand decline.
-554.55%
Negative EBIT growth while RUN is at 1.82%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-215.67%
Negative operating income growth while RUN is at 1.82%. Joel Greenblatt would press for urgent turnaround measures.
-390.49%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-296.15%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-296.15%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-38.35%
Share reduction while RUN is at 0.55%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-38.35%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-697.99%
Negative OCF growth while RUN is at 25.12%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-612.15%
Negative FCF growth while RUN is at 228.63%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-98.55%
Negative 10Y revenue/share CAGR while RUN stands at 239.45%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-97.80%
Negative 5Y CAGR while RUN stands at 31.08%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-96.08%
Negative 3Y CAGR while RUN stands at 12.80%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-15.34%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-12.63%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-107.79%
Negative 3Y OCF/share CAGR while RUN stands at 20.10%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-523.77%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-882.15%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-111.99%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-117.92%
Negative equity/share CAGR over 10 years while RUN stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-61.98%
Negative 5Y equity/share growth while RUN is at 199.51%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-189.42%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-34.77%
Firm’s AR is declining while RUN shows 1.42%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-70.14%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
223.24%
Asset growth above 1.5x RUN's 3.08%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-151.68%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
191.33%
Debt growth far above RUN's 3.75%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
211.71%
SG&A growth well above RUN's 14.06%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.